Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipelineDren Bio deep B-cell ...

Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi has agreed to acquire DR-0201, a targeted bispecific myeloid ...

CERo Therapeutics Holdings, Inc., (NASDAQ: CERO) shares were unchanged. The company, an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that ...

A vivid new image is taking shape in the world of cell biology: Imagine bacteria adhering to the surface of a cell, perhaps ...

Sanofi to acquire Dren Bio's bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline Dren Bio deep B-cell depleter program has the potential to reset the immune syste ...

Nasal anti-CD3 spray reduces traumatic brain injury in mice, a potential breakthrough for TBI treatment. Read now.

Phagocytosis is a fundamental mechanism used by the body to resist pathogens and restore physiological homeostasis. Herein, to identify small molecules with anti-inflammatory properties via ...

ZyVersa highlights newly published data demonstrating that NLRP3 Inhibition attenuates development of AD pathology and neuroinflammation in a ...

New poster to highlight preclinical data of CER-1236 in ovarian cancer SOUTH SAN FRANSCISCO, Calif., March 05, 2025 (GLOBE ...

But when they eat dead bacteria it doesn't. "When phagocytic cells eat dead bacteria some of the small molecules they recycle tell them not to induce inflammation, that everything is going to be fine, ...

Their comments, offering an alternative interpretation of our data, are based on the idea that some phagocytic receptors are 'more equal than others'. Two other results emerged from our study.